Skip to main content
. 2012 Aug 13;120(13):2658–2668. doi: 10.1182/blood-2011-05-355396

Figure 5.

Figure 5

Histopathologic analysis of mice treated with dasatinib + plerixafor shows slightly increased infiltration of leukemic cells in all organs compared with dasatinib only treatment. Spleen, liver, lung, and bone marrow sections were stained with hematoxylin and eosin.